Sponsor Pipeline

Compass Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Phase 3
10
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05506943 A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable… Biliary Tract Cancer Active, Not Recruiting
Phase 2
NCT07684170 Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive… Neuroendocrine Neoplasm Not Yet Recruiting
Phase 1
NCT06150664 A Phase 1 of CTX-8371 in Patients With Advanced Malignancies Non Small Cell Lung Cancer Recruiting
NCT07419841 A Phase 1 Study of the Safety and Tolerability of CTX-10726 Gastroesophageal Cancer (GC) Recruiting
Disease Areas
Bladder Cancer (1) Cholangiocarcinoma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Melanoma (1) Hodgkin Lymphoma (1) Head & Neck Cancer (1) Liver Cancer (1)
Get alerts when Compass Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free